2009
DOI: 10.1016/j.vaccine.2009.09.050
|View full text |Cite
|
Sign up to set email alerts
|

Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
43
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 36 publications
(50 citation statements)
references
References 51 publications
7
43
0
Order By: Relevance
“…Similar to other specific-bradyzoite proteins in T. gondii (Di Cristina et al 2004), its immunogenicity seems to be reduced when compared to secreted/excreted proteins (Aguado- Martínez et al 2008Martínez et al , 2009a). This reduction serves as an immune evasion mechanism, allowing it to persist in the host (Kim and Boothroyd 2005).…”
Section: Discussionmentioning
confidence: 93%
“…Similar to other specific-bradyzoite proteins in T. gondii (Di Cristina et al 2004), its immunogenicity seems to be reduced when compared to secreted/excreted proteins (Aguado- Martínez et al 2008Martínez et al , 2009a). This reduction serves as an immune evasion mechanism, allowing it to persist in the host (Kim and Boothroyd 2005).…”
Section: Discussionmentioning
confidence: 93%
“…In addition, we assume that this response remained active after the infection, since sera from vaccinated and challenged animals recognized the same specific bands by Western blotting. Hence, the lack of a protective effect cannot be attributed to a lack of immune stimulation against the original protein as reported in previous studies (Cannas et al, 2003a;Aguado-Martínez et al, 2009;Jiménez-Ruiz et al, 2012).…”
Section: Discussionmentioning
confidence: 68%
“…In the present work, NcROP40 and NcNTPase, which are more abundantly expressed in high virulence isolates (Regidor-Cerrillo et al, 2012), were expressed as recombinant proteins and assessed as vaccine candidates, either as monovalent vaccines or in combination with NcROP2 and NcGRA7 (Aguado-Martínez et al, 2009;Debache et al, 2009;Jiménez-Ruiz et al, 2012). Combining these vaccine candidates into a polyvalent formulation was done in anticipation to increase the efficacy of final formulations, since these antigens were selected based on their predicted functional role during the tachyzoite lytic cycle (Coppens et al, 1999;Ferguson, 2004;El Hajj et al, 2006;Cesbron-Delauw et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations